MRI and FDG-PET for Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer

被引:0
作者
Toshisada Aiba
Keisuke Uehara
Takashi Nihashi
Toyonori Tsuzuki
Hiroshi Yatsuya
Yuichiro Yoshioka
Katsuhiko Kato
Masato Nagino
机构
[1] Nagoya Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[2] Nagoya University Graduate School of Medicine,Department of Radiology
[3] Nagoya Daini Red Cross Hospital,Department of Pathology
[4] Fujita Health University School of Medicine,Department of Public Health
[5] Nagoya University Graduate School of Medicine,Department of Radiological and Medical Laboratory Sciences
来源
Annals of Surgical Oncology | 2014年 / 21卷
关键词
Rectal Cancer; Induction Chemotherapy; National Comprehensive Cancer Network; Pathological Response; Tumor Regression Grade;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1801 / 1808
页数:7
相关论文
共 102 条
[21]  
Vos B(2010)Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys. 78 164-1025
[22]  
Polus M(2012)MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy Radiology. 263 409-3760
[23]  
Chau I(2010)Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response Int J Radiat Oncol Biol Phys. 76 1018-1700
[24]  
Brown G(2011)Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience J Clin Oncol. 29 3753-1040
[25]  
Cunningham D(2012)Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer Eur Radiol. 22 1693-615
[26]  
Schrag D(2012)Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT Abdom Imaging. 37 1032-1557
[27]  
Weiser MR(2007)18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy Tumori. 93 611-1207
[28]  
Goodman KA(2009)18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer Eur J Nucl Med Mol Imaging. 36 1551-97
[29]  
Fernandez-Martos C(2013)Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy Cancer Chemother Pharmacol. 71 1201-1224
[30]  
Estevan R(2013)The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer Eur J Nucl Med Mol Imaging. 40 91-2185